103 related articles for article (PubMed ID: 1690524)
1. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
Lafrado LJ; Mathes LE; Zack PM; Olsen RG
Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
[TBL] [Abstract][Full Text] [Related]
2. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
Engelman RW; Good RA; Day NK
Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
[TBL] [Abstract][Full Text] [Related]
3. Study of feline leukemia virus immunity.
Charreyre C; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
[TBL] [Abstract][Full Text] [Related]
4. Acute feline leukemia virus infection causes altered energy balance and growth inhibition in weanling cats.
Hartke JR; Hayes KA; Buffington CA; Mathes LE; Rojko JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):11-9. PubMed ID: 7712229
[TBL] [Abstract][Full Text] [Related]
5. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
6. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
7. Effects of feline leukemia virus infection on neutrophil chemotaxis in vitro.
Kiehl AR; Fettman MJ; Quackenbush SL; Hoover EA
Am J Vet Res; 1987 Jan; 48(1):76-80. PubMed ID: 3030165
[TBL] [Abstract][Full Text] [Related]
8. [Paramunization of FeLV-positive cats with PIND-AVI].
Hörber D; Mayr B
Tierarztl Prax; 1991 Jun; 19(3):311-4. PubMed ID: 1653471
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for feline leukemia, using staphylococcal protein A or heterologous interferons: immunopharmacologic actions and potential use.
Weiss RC
J Am Vet Med Assoc; 1988 Mar; 192(5):681-4. PubMed ID: 2453494
[No Abstract] [Full Text] [Related]
10. Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats.
Hawks DM; Legendre AM; Rohrbach BW; Sebring R; Chavez L; Chu HJ; Acree WM
J Am Vet Med Assoc; 1991 Nov; 199(10):1463-9. PubMed ID: 1666104
[TBL] [Abstract][Full Text] [Related]
11. Immunologic profiles of cats with persistent, naturally acquired feline leukemia virus infection.
Reimann KA; Bull RW; Crow SE; Coffman P; Raskin RE
Am J Vet Res; 1986 Sep; 47(9):1935-9. PubMed ID: 3021028
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
Hines DL; Cutting JA; Dietrich DL; Walsh JA
J Am Vet Med Assoc; 1991 Nov; 199(10):1428-30. PubMed ID: 1666097
[TBL] [Abstract][Full Text] [Related]
13. Incidence of localized feline leukemia virus infection in cats.
Hayes KA; Rojko JL; Mathes LE
Am J Vet Res; 1992 Apr; 53(4):604-7. PubMed ID: 1316726
[TBL] [Abstract][Full Text] [Related]
14. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection.
Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW
J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure.
Legendre AM; Hawks DM; Sebring R; Rohrbach B; Chavez L; Chu HJ; Acree WM
J Am Vet Med Assoc; 1991 Nov; 199(10):1456-62. PubMed ID: 1666103
[TBL] [Abstract][Full Text] [Related]
16. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.
Gomes-Keller MA; Tandon R; Gönczi E; Meli ML; Hofmann-Lehmann R; Lutz H
Vet Microbiol; 2006 Jan; 112(1):11-21. PubMed ID: 16303261
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
Engelman RW; Tyler RD; Trang LQ; Liu WT; Good RA; Day NK
Am J Pathol; 1985 Mar; 118(3):367-78. PubMed ID: 2983560
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets.
Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650
[TBL] [Abstract][Full Text] [Related]
19. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of three commercial feline leukemia virus vaccines against methylprednisolone acetate-augmented oronasal challenge exposure with virulent virus.
Pedersen NC; Johnson L
J Am Vet Med Assoc; 1991 Nov; 199(10):1453-5. PubMed ID: 1666102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
